siltuximab - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Can fewer infusions improve adherence in Fabry disease enzyme replacement therapy?

CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m

What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)

CVGI surges 54% as CVG names Zoox strategic supplier and issues $700M revenue outlook for 2026

Read More

2 minute read

Pharma Industry News

Eusa Pharma completes $115m acquisition of Sylvant for iMCD treatment

Eusa Pharma has successfully acquired the global rights to Sylvant (siltuximab), a drug used in the treatment of…

bypharmanewsdaily

January 20, 2019

web analytics